Articles Archives - Page 2 of 2 - Porterhouse Medical

27 September 2018

Behaviour change: Five things you probably suspected, but weren’t sure about…

Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.

Genetic obesity_Jeans for Genes Day 2018

20 September 2018

Genetic obesity syndromes: What is beyond the obesogenic environment?

It is widely believed that obesity is caused by eating too much and moving too little. But, what about those people who can’t lose weight, despite having a healthy diet and doing regular exercise? What if there is something else beyond the ‘obesogenic’ environment?

14 September 2018

World Lymphoma Awareness Day: Advances in the treatment of lymphatic cancer

Every year, on 15 September, the global population unites for World Lymphoma Awareness Day to raise awareness of cancers of the lymphatic system.

At Porterhouse, we are proud and passionate about the work we do with our partners to help improve people’s lives. In this instance, we would like to share some facts about the latest advances for the treatment of lymphatic cancer.

10 September 2018

Alzheimer’s disease: Current standing and new hopes

Can you imagine waking up in a house unrecognisably new to you every morning for the rest of your life? Not being able to find your kitchen to make a cup of tea? Not being able to recognise your loved ones? Most of us cannot conceive these situations, but they are the reality for millions of patients with Alzheimer’s disease (AD) worldwide.

7 August 2018

New ICMJE guidelines and their impact on biotech

Kevin Ryder, Porterhouse Medical US, discusses the significant publications challenges faced by smaller biotechnology and pharma companies

11 July 2018

Why can’t we use Google Maps to understand patient journeys?

Patient experiences are diverse and dynamic. Mapping patient journeys enables us to unlock salient insights and redesign care pathways.

10 July 2018

Developing advocacy in the pharmaceutical industry. The importance of advocacy programmes

Brian Parsons, joint MD of the Porterhouse Medical Group and advocacy expert, highlights the importance of advocacy and how to get the best from advocacy programmes in the pharmaceutical industry.

13 June 2018

It’s all about patient outcomes… right?

In late 1846, a dentist from New England, William TG Morton, is attributed to have performed a dental extraction using diethyl ether as a general anaesthetic. While there was much subsequent debate around who pioneered the birth of modern anaesthesia, what is undeniable is the speed with which the practice spread among the medical profession and the impact it had on medicine.1

30 May 2018

Research is bringing us closer to ending Multiple Sclerosis

World Multiple Sclerosis (MS) Day is an initiative of the MS International Federation that is marked on 30 May every year. The 2018 campaign called #bringinguscloser focuses on research and connecting those affected by MS to those involved in researching it

29 May 2018

Beyond the event

There’s no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs of the audience and organiser’s time. Therefore, it’s vital for meeting owners to maximise the value of their investment, and for attendees to feel like it was a worthwhile use of their time.

27 April 2018

Living with haemophilia – the power of knowledge

In honour of World Hemophilia Day, we are considering the importance of sharing knowledge. Before delving into this topic, it is important to understand what haemophilia is and the impact it has on those suffering from it.

10 February 2018

For Rare Disease Day, here we describe five interesting facts about rare diseases.

The Rare Disease Day campaign aims to combat these issues by raising awareness among the public, healthcare professionals, researchers, industry, and policy decision-makers.

News: Articles